SCHEMBL7616016

SCHEMBL7616016

CS(=O)(=O)N(Cc1ccccc1)c1cccc(C(=O)CN(CCO)Cc2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.47
MEN1 O00255 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 4/20 0.45
LMNA P02545 3/20 0.45
PTPN1 P18031 2/20 0.43
GRM2 Q14416 1/20 0.43
POLB P06746 1/20 0.43
PTPN6 P29350 1/20 0.42
PTPN11 Q06124 1/20 0.42
PPARG P37231 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.41
ACHE P22303 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7244570 0.92 KMT2A (0.52) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
SCHEMBL7619230 0.91 KMT2A (0.47) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
Hydrochloric Acid SCHEMBL7243072 0.91 KMT2A (0.51) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
Hydrochloric Acid SCHEMBL7655442 0.90 KMT2A (0.47) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
Bromide SCHEMBL7620268 0.90 KMT2A (0.47) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
SCHEMBL7250194 0.83 KMT2A (0.53) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
SCHEMBL7618868 0.83 ACHE (0.42) KMT2AMEN1SMN1; SMN2ALDH1A1PPARG
SCHEMBL7615925 0.82 PPARG (0.49) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
SCHEMBL7250273 0.81 KMT2A (0.53) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
SCHEMBL6744201 0.80 KMT2A (0.69) KMT2AMEN1ALDH1A1LMNAGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6495701-B1 THE PRESENT INVENTION IS DIRECTED TO PROCESSES FOR THE PREPARATION OF A COMPOUND USEFUL FOR TREATING DIABETES, OBESITY, HYPERLIPIDEMIA AND THE LIKE, ASAHI KASEI KABUSHIKI KAISHA (JP) 2002-12-17 US disclosed
EP-1174425-A1 NOVEL METHOD FOR MANUFACTURING TRICYCLIC AMINO ALCOHOL DERIVATIVES Asahi Kasei Kabushiki Kaisha (JP) 2002-01-23 EP disclosed